These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 28592009)

  • 21. [Analysis of clinical features of 6 patients with infantile type glycogen storage disease type II].
    Ding J; Huang Y; Yang H; Zhang Q; Hou X; Liu X; Yang Y; Xiong H
    Zhonghua Er Ke Za Zhi; 2015 Jun; 53(6):436-41. PubMed ID: 26310554
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical sequelae of 17 cases with glycogen storage disease type II/Pompe disease].
    Zhang HB; Zhang WM; Qiu JJ; Meng Y; Qiu ZQ
    Zhonghua Er Ke Za Zhi; 2012 Jun; 50(6):415-9. PubMed ID: 22931935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glycogen storage diseases presenting as hypertrophic cardiomyopathy.
    Arad M; Maron BJ; Gorham JM; Johnson WH; Saul JP; Perez-Atayde AR; Spirito P; Wright GB; Kanter RJ; Seidman CE; Seidman JG
    N Engl J Med; 2005 Jan; 352(4):362-72. PubMed ID: 15673802
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adenovirus-mediated transfer of the acid alpha-glucosidase gene into fibroblasts, myoblasts and myotubes from patients with glycogen storage disease type II leads to high level expression of enzyme and corrects glycogen accumulation.
    Nicolino MP; Puech JP; Kremer EJ; Reuser AJ; Mbebi C; Verdière-Sahuqué M; Kahn A; Poenaru L
    Hum Mol Genet; 1998 Oct; 7(11):1695-702. PubMed ID: 9736771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular analysis and protein processing in late-onset Pompe disease patients with low levels of acid α-glucosidase activity.
    Bali DS; Tolun AA; Goldstein JL; Dai J; Kishnani PS
    Muscle Nerve; 2011 May; 43(5):665-70. PubMed ID: 21484825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of a feasible assay for the detection of GAA mutations in patients with Pompe disease.
    Er TK; Chen CC; Chien YH; Liang WC; Kan TM; Jong YJ
    Clin Chim Acta; 2014 Feb; 429():18-25. PubMed ID: 24444888
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glycogen-storage disease type II (acid maltase deficiency): identification of a novel small deletion (delCC482+483) in French patients.
    Nicolino M; Puech JP; Letourneur F; Fardeau M; Kahn A; Poenaru L
    Biochem Biophys Res Commun; 1997 Jun; 235(1):138-41. PubMed ID: 9196050
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A newly identified c.1824_1828dupATACG mutation in exon 13 of the GAA gene in infantile-onset glycogen storage disease type II (Pompe disease).
    Aryani O; Manshadi MD; Tondar M; Khalili E; Kamalidehghan B; Ahmadipour F; Fani S; Houshmand M
    Mol Biol Rep; 2014 Sep; 41(9):6211-4. PubMed ID: 24976573
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Application of enzyme assay and gene analysis in the prenatal diagnosis for a family with glycogen storage disease type II].
    Zeng MH; Qiu WJ; Gu XF; Wang Y; Zhou JD; Ye J; Han LS; Zhang HW
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2011 Jun; 28(3):261-5. PubMed ID: 21644219
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeted gene panel screening is an effective tool to identify undiagnosed late onset Pompe disease.
    Savarese M; Torella A; Musumeci O; Angelini C; Astrea G; Bello L; Bruno C; Comi GP; Di Fruscio G; Piluso G; Di Iorio G; Ergoli M; Esposito G; Fanin M; Farina O; Fiorillo C; Garofalo A; Giugliano T; Magri F; Minetti C; Moggio M; Passamano L; Pegoraro E; Picillo E; Sampaolo S; Santorelli FM; Semplicini C; Udd B; Toscano A; Politano L; Nigro V
    Neuromuscul Disord; 2018 Jul; 28(7):586-591. PubMed ID: 29880332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glycogen stored in skeletal but not in cardiac muscle in acid alpha-glucosidase mutant (Pompe) mice is highly resistant to transgene-encoded human enzyme.
    Raben N; Jatkar T; Lee A; Lu N; Dwivedi S; Nagaraju K; Plotz PH
    Mol Ther; 2002 Nov; 6(5):601-8. PubMed ID: 12409258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [GAA gene variants and genotype-phenotype correlations in patients with glycogen storage disease type Ⅱ].
    Huang YL; Sheng HY; Jia XF; Su XY; Zhao XY; Xie T; Tang CF; Liu SC; Li XZ; Zhang W; Mei HF; Zeng CH; Liu L
    Zhonghua Er Ke Za Zhi; 2021 Mar; 59(3):189-194. PubMed ID: 33657692
    [No Abstract]   [Full Text] [Related]  

  • 33. The Novel Compound Heterozygous Mutations of GAA Gene in Mainland Chinese Patient with Classic Infantile-Onset Pompe Disease.
    Li J; Cui Y; Wang X; Wang Q; Wang H; Yan B
    Int Heart J; 2020 Jan; 61(1):178-182. PubMed ID: 31875618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Twenty-two novel mutations in the lysosomal alpha-glucosidase gene (GAA) underscore the genotype-phenotype correlation in glycogen storage disease type II.
    Hermans MM; van Leenen D; Kroos MA; Beesley CE; Van Der Ploeg AT; Sakuraba H; Wevers R; Kleijer W; Michelakakis H; Kirk EP; Fletcher J; Bosshard N; Basel-Vanagaite L; Besley G; Reuser AJ
    Hum Mutat; 2004 Jan; 23(1):47-56. PubMed ID: 14695532
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Remarkably low fibroblast acid α-glucosidase activity in three adults with Pompe disease.
    Wens SC; Kroos MA; de Vries JM; Hoogeveen-Westerveld M; Wijgerde MG; van Doorn PA; van der Ploeg AT; Reuser AJ
    Mol Genet Metab; 2012 Nov; 107(3):485-9. PubMed ID: 23000108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of the promoter region and gene expression for human acid alpha glucosidase.
    Tzall S; Martiniuk F
    Biochem Biophys Res Commun; 1991 May; 176(3):1509-15. PubMed ID: 1645546
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of Seven Novel Mutations in the Acid Alpha-glucosidase Gene in Five Chinese Patients with Late-onset Pompe Disease.
    Liu HX; Pu CQ; Shi Q; Zhang YT; Ban R
    Chin Med J (Engl); 2018 Feb; 131(4):448-453. PubMed ID: 29451150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced efficacy of an AAV vector encoding chimeric, highly secreted acid alpha-glucosidase in glycogen storage disease type II.
    Sun B; Zhang H; Benjamin DK; Brown T; Bird A; Young SP; McVie-Wylie A; Chen YT; Koeberl DD
    Mol Ther; 2006 Dec; 14(6):822-30. PubMed ID: 16987711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correction of glycogen storage disease type II by enzyme replacement with a recombinant human acid maltase produced by over-expression in a CHO-DHFR(neg) cell line.
    Martiniuk F; Chen A; Donnabella V; Arvanitopoulos E; Slonim AE; Raben N; Plotz P; Rom WN
    Biochem Biophys Res Commun; 2000 Oct; 276(3):917-23. PubMed ID: 11027569
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adult glycogenosis type II (Pompe's disease): morphological abnormalities in muscle and skin biopsies compared with acid alpha-glucosidase activity.
    Wierzba-Bobrowicz T; Lewandowska E; Lugowska A; Rola R; Stepień T; Ryglewicz D; Pasennik E
    Folia Neuropathol; 2007; 45(4):179-86. PubMed ID: 18176891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.